Natural product-based nanotechnological formulations for colorectal cancer treatment
- PMID: 40274619
- DOI: 10.1007/s00210-025-04175-y
Natural product-based nanotechnological formulations for colorectal cancer treatment
Abstract
Colorectal cancer is one of the most common malignancies affecting the gastrointestinal tract. A silent onset often marks it and carries a poor prognosis. Studies have shown that natural products can suppress the growth of colorectal cancer and exert therapeutic effects at the molecular level. However, unfavorable physicochemical properties frequently hinder their clinical application, such as low solubility, limited bioavailability, short half-life, and rapid systemic clearance. As scientific and technological progress continues, increasing attention has been directed toward nanotechnology-based approaches. Techniques involving nanoparticles, liposomes, and micelles are being explored to improve drug delivery. These advancements provide a promising foundation for overcoming the limitations associated with natural products. This review systematically examines the application of nano-formulations for natural ingredients to offer meaningful insights into their. potential use in treating colorectal cancer.
Keywords: Colorectal cancer; Combination therapy; Nanotechnology; Natural products; Targeted therapy.
© 2025. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Conflict of interest statement
Declarations. Ethcis approval: All authors read and approved the manuscript. Competing interests: The authors declare no competing interests.
Similar articles
-
Advances in nano drug delivery systems for enhanced efficacy of emodin in cancer therapy.Int J Pharm X. 2024 Dec 25;9:100314. doi: 10.1016/j.ijpx.2024.100314. eCollection 2025 Jun. Int J Pharm X. 2024. PMID: 39834843 Free PMC article. Review.
-
Nanotechnology-Based Drug Delivery Systems for Honokiol: Enhancing Therapeutic Potential and Overcoming Limitations.Int J Nanomedicine. 2023 Nov 13;18:6639-6665. doi: 10.2147/IJN.S431409. eCollection 2023. Int J Nanomedicine. 2023. PMID: 38026538 Free PMC article. Review.
-
Nano-Drug Delivery Systems Based on Natural Products.Int J Nanomedicine. 2024 Jan 18;19:541-569. doi: 10.2147/IJN.S443692. eCollection 2024. Int J Nanomedicine. 2024. PMID: 38260243 Free PMC article. Review.
-
Niosomes as a Promising Therapeutic Approach against Colorectal Cancer: A Focus on the Delivery of Chemotherapeutics and Natural Products.Curr Pharm Des. 2024;30(21):1659-1666. doi: 10.2174/0113816128303645240429052835. Curr Pharm Des. 2024. PMID: 38747232 Review.
-
Unveiling the Pharmacological and Nanotechnological Facets of Daidzein: Present State-of-the-Art and Future Perspectives.Molecules. 2023 Feb 13;28(4):1765. doi: 10.3390/molecules28041765. Molecules. 2023. PMID: 36838751 Free PMC article. Review.
References
-
- Abbasinia H, Heshmati M, Yousefi M et al (2023) Silymarin-loaded tin(IV) nanoparticles exhibit enhanced bioavailability and antiproliferative effects on colorectal cancer cells. ACS Appl Bio Mater 6:3768–3777. https://doi.org/10.1021/acsabm.3c00434 - DOI - PubMed
-
- AbouAitah K, Hassan H, Swiderska-Sroda A et al (2020) Targeted nano-drug delivery of colchicine against colon cancer cells by means of mesoporous silica nanoparticles. Cancers 12. https://doi.org/10.3390/cancers12010144
-
- Ahmadi F, Ghasemi-Kasman M, Ghasemi S et al (2017) Induction of apoptosis in HeLa cancer cells by an ultrasonic-mediated synthesis of curcumin-loaded chitosan-alginate-STPP nanoparticles. Int J Nanomedicine 12:8545–8556. https://doi.org/10.2147/IJN.S146516 - DOI - PubMed - PMC
-
- Al-Asmari AK, Ullah Z, Al Balowi A, Islam M (2017) In vitro determination of the efficacy of scorpion venoms as anti-cancer agents against colorectal cancer cells: a nano-liposomal delivery approach. Int J Nanomedicine 12:559–574. https://doi.org/10.2147/IJN.S123514 - DOI - PubMed - PMC
-
- Alibolandi M, Taghdisi SM, Ramezani P et al (2017) Smart AS1411-aptamer conjugated pegylated PAMAM dendrimer for the superior delivery of camptothecin to colon adenocarcinoma in vitro and in vivo. Int J Pharm 519:352–364. https://doi.org/10.1016/j.ijpharm.2017.01.044 - DOI - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials